Development of Vaccines 2011
DOI: 10.1002/9781118023648.ch13
|View full text |Cite
|
Sign up to set email alerts
|

Selection of Optimal Adjuvants and Product Factors that Affect Vaccine Immunogenicity

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

0
2
0

Year Published

2014
2014
2014
2014

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(2 citation statements)
references
References 434 publications
0
2
0
Order By: Relevance
“…Wang and Singh interpreted the lack of approval of novel and more efficient adjuvants to the basic dogma in vaccinology: a single adjuvant should be used unless it is not effective, that is, keep it simple and stupid. 129 In the forthcoming years, this dogma will have to give way to the hybrid biomimetic adjuvants which are already revealing their superior performance as discussed in the last section of this chapter. For vaccines, targeting means delivering the antigen to the lymph nodes, antigenpresenting cells (APC) or B-cells, and within cells lysosome or cytoplasm.…”
Section: Nanomedicines Based On Biocompatible Polymersmentioning
confidence: 96%
See 1 more Smart Citation
“…Wang and Singh interpreted the lack of approval of novel and more efficient adjuvants to the basic dogma in vaccinology: a single adjuvant should be used unless it is not effective, that is, keep it simple and stupid. 129 In the forthcoming years, this dogma will have to give way to the hybrid biomimetic adjuvants which are already revealing their superior performance as discussed in the last section of this chapter. For vaccines, targeting means delivering the antigen to the lymph nodes, antigenpresenting cells (APC) or B-cells, and within cells lysosome or cytoplasm.…”
Section: Nanomedicines Based On Biocompatible Polymersmentioning
confidence: 96%
“…128 Wang and Singh comprehensively reviewed the literature on the selection of optimal adjuvants for vaccines. 129 Because of the limited adjuvant effect of aluminum salts which induce only a Th2 response, 130 other nonaluminum adjuvants (often not approved by the FDA in the U.S.) have been searched and tried extensively over the last 20 years. 131,132 Among these, polymeric particles made of biocompatible polymers such as polylactic acid (PLA), poly(lactide-co-glycolide) acid (PLGA), 133 chitosan, 134 poly(γ-glutamic acid) (γ-PGA), 135 and starch.…”
Section: Nanomedicines Based On Biocompatible Polymersmentioning
confidence: 99%